SCHEMBL13503572

SCHEMBL13503572

CC(C)C1CCC(=Cc2ccccc2Cl)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
HTT P42858 1/20 0.46
DYRK2 Q92630 1/20 0.38
ALDH1A1 P00352 4/20 0.36
XDH P47989 2/20 0.35
EGFR P00533 2/20 0.34
PIM1 P11309 1/20 0.34
S1PR3 Q99500 1/20 0.33
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32
CDK2 P24941 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
CCR3 P51677 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503723 0.85 MAPT (0.33) MAPTNPSR1HTT
SCHEMBL13503570 0.82 MEN1 (0.34) MAPTNPSR1HTTALDH1A1MEN1
SCHEMBL13503833 0.81 MAPT (0.45) MAPTNPSR1HTTDYRK2ALDH1A1
SCHEMBL13504037 0.81 MAPT (0.42) MAPTNPSR1HTTMEN1LMNA
SCHEMBL13503567 0.81 HSD11B1 (0.44) MAPTDYRK2EGFRMEN1KMT2A
SCHEMBL14409763 0.81 OPRM1 (0.31)
SCHEMBL13503573 0.81 MAPT (0.46) MAPTDYRK2ALDH1A1EGFRMEN1
SCHEMBL13503694 0.78 ALDH1A1 (0.41) MAPTALDH1A1EGFRMEN1HPGD
SCHEMBL17684689 0.78 MAPT (0.42) MAPTNPSR1HTTDYRK2ALDH1A1
SCHEMBL13503566 0.75 MAPT (0.35) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-7585858-B2 N-sulfonylcarboximidamide apoptosis promoters ABBOTT LABORATORIES (US) 2009-09-08 US disclosed
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed
US-7358251-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2008-04-15 US disclosed
US-7358251-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2008-04-15 US disclosed
EP-1487811-B1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LAB (US) 2007-09-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS BAX, BCL2, BAD MAPT 4694/4885NPSR1 3717/4885HTT 2091/4885
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS BAX, BCL2, BAD MAPT 4433/4885NPSR1 4070/4885HTT 2129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.